Medication info
Amotin Tablets (Famotidine)

Amotin Tablets (Famotidine)

Prescription medicationTablet
Ingredient · strength
Famotidine›20mg / 1 tablet
Manufacturer / importer
Austin Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablets
Packaging
30 tablets/bottle, 200 tablets/bottle
Approval status
Active

MFDS item code 200402057 · Notified 2004.07.07 · Insurance code 654301790

Summary

Main use
Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, and prevention of upper gastrointestinal bleeding
Who uses it
Adults
Adult dosage
(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger–Ellison syndrome: Adults should take famotidine 20 mg orally per dose 2 times daily (after breakfast and dinner or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection, and switched to oral administration when oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10 mg orally per dose 2 times daily (after breakfast and dinner or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20 mg per dose in 20 mL of normal saline injection or dextrose injection and administer slowly by intravenous injection 2 times daily (every 12 hours), or mix with an infusion solution and administer by intravenous infusion. For upper gastrointestinal bleeding and Zollinger–Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration when oral administration becomes possible. When used as preanesthetic medication, dissolve 20 mg per dose in 1–1.5 mL of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20 mL of normal saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Manufacturer
Austin Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of gastrointestinal disorders (ulcers, gastritis, etc.), preanesthetic medication, and prevention of upper gastrointestinal bleeding

  • Gastric ulcer
  • duodenal ulcer
  • anastomotic ulcer
  • upper gastrointestinal bleeding
  • acute stress ulcer
  • hemorrhagic gastritis
  • gastroesophageal reflux disease
  • Zollinger-Ellison syndrome
  • gastric mucosal lesions
  • erosions
  • bleeding
  • erythema
View approved original text

This medication is used in oral and injectable forms and is primarily effective for digestive ulcer diseases such as gastric and duodenal ulcers and anastomotic ulcers. It also helps treat upper gastrointestinal bleeding due to acute stress ulcers and hemorrhagic gastritis. It can improve lesions of the gastric mucosa such as erosions, bleeding, erythema, and edema in patients with gastroesophageal reflux disease and Zollinger-Ellison syndrome. This medication is also used during acute exacerbations of acute and chronic gastritis. The injectable form is especially suitable for treating upper gastrointestinal bleeding and administering before anesthesia. This medication alleviates the symptoms of gastrointestinal diseases and protects the gastric mucosa, thereby improving health.

Dosage and Administration

Adult dosage

(Oral) 1. Gastric and duodenal ulcers, anastomotic ulcers, upper gastrointestinal bleeding (due to peptic ulcers, acute stress ulcers, or bleeding ulcers), reflux esophagitis, Zollinger–Ellison syndrome: Adults should take famotidine 20 mg orally per dose 2 times daily (after breakfast and dinner or at bedtime), or 40 mg orally once daily (at bedtime). For upper gastrointestinal bleeding, treatment is generally initiated with an injection, and switched to oral administration when oral administration becomes possible. 2. Improvement of gastric mucosal lesions (erosion, bleeding, redness, edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis Adults: Take famotidine 10 mg orally per dose 2 times daily (after breakfast and dinner or at bedtime), or 20 mg orally once daily (at bedtime). Adjust the dose as appropriate according to age and symptoms. (Injection) Adults: Dissolve famotidine 20 mg per dose in 20 mL of normal saline injection or dextrose injection and administer slowly by intravenous injection 2 times daily (every 12 hours), or mix with an infusion solution and administer by intravenous infusion. For upper gastrointestinal bleeding and Zollinger–Ellison syndrome, an effect is generally seen within 1 week. Switch to oral administration when oral administration becomes possible. When used as preanesthetic medication, dissolve 20 mg per dose in 1–1.5 mL of water for injection and administer intramuscularly 1 hour before induction of anesthesia, or dissolve in 20 mL of normal saline injection or dextrose injection and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dissolution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should not be used in patients who have experienced allergic reactions to its components or other H2 receptor antagonists. Also, since it contains lactose, it should not be administered to patients with genetically determined lactose degradation disorders. Patients with drug allergies, impaired renal function, heart diseases, impaired liver function, and the elderly should use this medication with caution. Patients with impaired kidney function may experience elevated blood drug concentration, so the dosage should be adjusted or the dosing interval extended. Serious side effects such as allergic reactions, blood abnormalities, severe skin diseases, liver dysfunction, muscle abnormalities, heart arrhythmias, changes in consciousness, kidney problems, and pneumonia may occur during the use of this medication, so careful observation is required. If any adverse reactions occur, the medication should be discontinued immediately, and medical advice should be sought. During treatment, regular blood tests and liver and kidney function tests should be conducted. This medication dissolves in the mouth but is not absorbed through the oral mucosa, so it must be swallowed with saliva or water. If a patient undergoing hemodialysis uses this medication along with specific phosphate binders, the drug's efficacy may decrease, so caution is needed. This medication may also affect drug concentrations and efficacy when taken with certain antifungal and specific anticancer drugs, so consulting a physician is necessary. Elderly patients may require dosage adjustments due to elevated drug concentrations stemming from impaired renal function. Women who are pregnant or may become pregnant should only use this medication if the benefits outweigh the risks, as its safety during pregnancy is not confirmed. Breastfeeding women should discontinue breastfeeding as this medication can be passed into breast milk. The safety for pediatric patients has not been sufficiently established, so caution should be exercised in use. Finally, this medication may mask symptoms of gastric cancer, so it should only be used when it is definitely not gastric cancer.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • generalized rash
  • angioedema
  • facial swelling
  • pharyngeal edema
  • urticaria
  • pancytopenia
Show 88 more
  • agranulocytosis
  • aplastic anemia
  • hemolytic anemia
  • thrombocytopenia
  • generalized malaise
  • weakness
  • subcutaneous hemorrhage
  • mucosal hemorrhage
  • fever
  • Stevens-Johnson syndrome
  • mucocutaneous syndrome
  • Riel syndrome
  • toxic epidermal necrolysis
  • hepatic dysfunction
  • jaundice
  • elevated AST
  • elevated ALT
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • elevated serum muscle enzymes
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • generalized seizures
  • tonic seizures
  • clonic seizures
  • interstitial nephritis
  • acute renal failure
  • rash
  • urticaria
  • abnormal renal function test results
  • interstitial pneumonia
  • high fever
  • cough
  • dyspnea
  • abnormal chest X-ray
  • diminished contraction
  • rash
  • urticaria
  • erythema
  • facial swelling
  • leukopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • elevated blood pressure
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • elevated ALP
  • increased total bilirubin
  • elevated LDH
  • hepatitis
  • generalized malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • excitement
  • decreased libido
  • sensory disturbances
  • heavy feeling in the head
  • reversible confusion state
  • depression
  • dizziness
  • menstrual irregularities
  • gynecomastia
  • arthralgia
  • elevated CK
  • elevated CPK
  • dysgeusia
  • muscle cramps

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering. It is recommended to maintain the storage temperature between 1 to 30 degrees Celsius at room temperature.

Appearance and packaging

Appearance

White round film-coated tablets

Package unit

30 tablets/bottle, 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.